| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| George A Ricaurte, Annis O Mechan, Jie Yuan, George Hatzidimitriou, Tao Xie, Andrew H Mayne, Una D McCan. Amphetamine treatment similar to that used in the treatment of adult attention-deficit/hyperactivity disorder damages dopaminergic nerve endings in the striatum of adult nonhuman primates. The Journal of pharmacology and experimental therapeutics. vol 315. issue 1. 2005-11-28. PMID:16014752. |
here we demonstrate that amphetamine treatment, similar to that used clinically for adult adhd, damages dopaminergic nerve endings in the striatum of adult nonhuman primates. |
2005-11-28 |
2023-08-12 |
Not clear |
| A Hurtado-Lorenzo, E Millan, V Gonzalez-Nicolini, D Suwelack, M G Castro, P R Lowenstei. Differentiation and transcription factor gene therapy in experimental parkinson's disease: sonic hedgehog and Gli-1, but not Nurr-1, protect nigrostriatal cell bodies from 6-OHDA-induced neurodegeneration. Molecular therapy : the journal of the American Society of Gene Therapy. vol 10. issue 3. 2005-11-22. PMID:15336651. |
the neurotoxin 6-hydroxydopamine was used to lesion the nigrostriatal dopaminergic innervation; rad-shhn and rad-gli-1 protected dopaminergic neuronal cell bodies in the substantia nigra, but not axonal terminals in the striatum, from 6-ohda-induced cell death, while rad-nurr-1 was ineffective in protecting either cell bodies or axons. |
2005-11-22 |
2023-08-12 |
rat |
| Emily Fitzpatrick, Keyoumars Ashkan, Bradley A Wallace, Alim-Louis Benabid, John Mitrofani. Differential survival patterns among midbrain dopaminergic cells of MPTP-treated monkeys and 6OHDA-lesioned rats. Anatomy and embryology. vol 210. issue 2. 2005-11-22. PMID:16151853. |
we suggest that the increase in antigen expression relates to the dopaminergic reinnervation of the striatum in mptp-treated cases. |
2005-11-22 |
2023-08-12 |
rat |
| Elzbieta Lorenc-Koci, Krystyna Gołembiowska, Jadwiga Warda. 1,2,3,4-Tetrahydroisoquinoline protects terminals of dopaminergic neurons in the striatum against the malonate-induced neurotoxicity. Brain research. vol 1051. issue 1-2. 2005-11-15. PMID:16004976. |
1,2,3,4-tetrahydroisoquinoline protects terminals of dopaminergic neurons in the striatum against the malonate-induced neurotoxicity. |
2005-11-15 |
2023-08-12 |
rat |
| S B Foster, H Tang, K E Miller, G Dryhurs. Increased extracellular glutamate evoked by 1-methyl-4-phenylpyridinium [MPP(+)] in the rat striatum is not essential for dopaminergic neurotoxicity and is not derived from released glutathione. Neurotoxicity research. vol 7. issue 4. 2005-11-15. PMID:16179262. |
increased extracellular glutamate evoked by 1-methyl-4-phenylpyridinium [mpp(+)] in the rat striatum is not essential for dopaminergic neurotoxicity and is not derived from released glutathione. |
2005-11-15 |
2023-08-12 |
rat |
| S B Foster, H Tang, K E Miller, G Dryhurs. Increased extracellular glutamate evoked by 1-methyl-4-phenylpyridinium [MPP(+)] in the rat striatum is not essential for dopaminergic neurotoxicity and is not derived from released glutathione. Neurotoxicity research. vol 7. issue 4. 2005-11-15. PMID:16179262. |
in the present investigation it is demonstrated that perfusions of solutions of 0.7 and 1.3 mm mpp(+) dissolved in artificial cerebrospinal fluid into the rat striatum evoke neurotoxic damage to dopaminergic terminals, assessed by both a two-day test/challenge procedure and tyrosine hydroxylase immunoreactivity, but without the release of glu. |
2005-11-15 |
2023-08-12 |
rat |
| Michelle Porritt, Davor Stanic, David Finkelstein, Peter Batchelor, Sharon Lockhart, Andrew Hughes, Renate Kalnins, David Howell. Dopaminergic innervation of the human striatum in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society. vol 20. issue 7. 2005-11-14. PMID:15726582. |
dopaminergic innervation of the human striatum in parkinson's disease. |
2005-11-14 |
2023-08-12 |
human |
| Martine Cossette, Daniel Lévesque, André Paren. Neurochemical characterization of dopaminergic neurons in human striatum. Parkinsonism & related disorders. vol 11. issue 5. 2005-11-10. PMID:15970454. |
neurochemical characterization of dopaminergic neurons in human striatum. |
2005-11-10 |
2023-08-12 |
human |
| Pao-Chi Liao, Yu-Min Kuo, Hen-Chia Hsu, Chienfang G Cherng, Lung Y. Local proteins associated with methamphetamine-induced nigrostriatal dopaminergic neurotoxicity. Journal of neurochemistry. vol 95. issue 1. 2005-11-08. PMID:16181420. |
infusion of anisomycin into striatum and substantia nigra both abolished the ma-induced striatal dopamine (da) and dihydroxyphenylacetic acid (dopac) depletions, indicating a critical role of local protein synthesis in determining such dopaminergic toxicity. |
2005-11-08 |
2023-08-12 |
Not clear |
| A K Wagner, J E Sokoloski, D Ren, X Chen, A S Khan, R D Zafonte, A C Michael, C E Dixo. Controlled cortical impact injury affects dopaminergic transmission in the rat striatum. Journal of neurochemistry. vol 95. issue 2. 2005-11-02. PMID:16190869. |
controlled cortical impact injury affects dopaminergic transmission in the rat striatum. |
2005-11-02 |
2023-08-12 |
rat |
| A J Lawrence, C L Parish, F Chen, D J Lodge, E V Krstew, K Card, D I Finkelstein, M K Horn. Chronic corticotropin-releasing factor type 1 receptor antagonism with antalarmin regulates the dopaminergic system of Fawn-Hooded rats. Journal of neurochemistry. vol 94. issue 6. 2005-10-27. PMID:16000149. |
following chronic antalarmin the density of dopaminergic terminals within the basal ganglia and amygdaloid complex were reduced, as was dopamine transporter binding within the striatum. |
2005-10-27 |
2023-08-12 |
rat |
| Dong-Youn Hwang, Sheila M Fleming, Paul Ardayfio, Taylor Moran-Gates, Hansoo Kim, Frank I Tarazi, Marie-Francoise Chesselet, Kwang-Soo Ki. 3,4-dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 25. issue 8. 2005-10-26. PMID:15728853. |
here, we demonstrate that pitx3-deficient aphakia (ak) mice, which have been shown previously to exhibit a major loss of substantia nigra dopaminergic neurons, display motor deficits that are reversed by l-dopa and evidence of "dopaminergic supersensitivity" in the striatum. |
2005-10-26 |
2023-08-12 |
mouse |
| W Michael Caudle, Jason R Richardson, Minzheng Wang, Gary W Mille. Perinatal heptachlor exposure increases expression of presynaptic dopaminergic markers in mouse striatum. Neurotoxicology. vol 26. issue 4. 2005-10-19. PMID:16112329. |
perinatal heptachlor exposure increases expression of presynaptic dopaminergic markers in mouse striatum. |
2005-10-19 |
2023-08-12 |
mouse |
| Jean-Bernard Dietrich, Aude Mangeol, Marie-Odile Revel, Claude Burgun, Dominique Aunis, Jean Zwille. Acute or repeated cocaine administration generates reactive oxygen species and induces antioxidant enzyme activity in dopaminergic rat brain structures. Neuropharmacology. vol 48. issue 7. 2005-10-11. PMID:15857623. |
either a single (acute) or repeated daily (chronic) injections (1 injection/day) of 20 mg/kg cocaine for 10 days to rats was found to increase reactive oxygen species production in two dopaminergic brain structures, the frontal cortex and the striatum. |
2005-10-11 |
2023-08-12 |
rat |
| Y Sasa. Directed differentiation of neural and sensory tissues from embryonic stem cells in vitro. Ernst Schering Research Foundation workshop. issue 54. 2005-10-11. PMID:16080289. |
these dopaminergic neurons are transplantable and survive well in the 6-ohda-treated mouse striatum. |
2005-10-11 |
2023-08-12 |
mouse |
| Pershia Samadi, Laurent Grégoire, Abdallah Hadj Tahar, Thérèse Di Paolo, Claude Rouillard, Paul J Bédar. Naltrexone in the short-term decreases antiparkinsonian response to l-Dopa and in the long-term increases dyskinesias in drug-naïve parkinsonian monkeys. Neuropharmacology. vol 49. issue 2. 2005-10-06. PMID:15996565. |
nigrostriatal dopaminergic denervation and levodopa therapy in animal models and in parkinsonian patients are associated with an enhanced opioid transmission in the striatum. |
2005-10-06 |
2023-08-12 |
human |
| Tetsuya Maeda, Ken Nagata, Yasuji Yoshida, Kazuya Kannar. Serotonergic hyperinnervation into the dopaminergic denervated striatum compensates for dopamine conversion from exogenously administered l-DOPA. Brain research. vol 1046. issue 1-2. 2005-09-27. PMID:15894297. |
serotonergic hyperinnervation into the dopaminergic denervated striatum compensates for dopamine conversion from exogenously administered l-dopa. |
2005-09-27 |
2023-08-12 |
rat |
| Eun Kyoung Ryu, Yearn Seong Choe, Eun Young Park, Jin-Young Paik, Yu Ri Kim, Kyung-Han Lee, Yong Choi, Sang Eun Kim, Byung-Tae Ki. Synthesis and evaluation of 2-[18F]fluoro-CP-118,954 for the in vivo mapping of acetylcholinesterase. Nuclear medicine and biology. vol 32. issue 2. 2005-09-08. PMID:15721764. |
a high level of uptake in the striatum was also shown at all time points in the olfactory tubercle, which is known to have dopaminergic neurons. |
2005-09-08 |
2023-08-12 |
mouse |
| E A Del Bel, F S Guimarães, M Bermúdez-Echeverry, M Z Gomes, A Schiaveto-de-souza, F E Padovan-Neto, V Tumas, A P Barion-Cavalcanti, M Lazzarini, L P Nucci-da-Silva, D de Paula-Souz. Role of nitric oxide on motor behavior. Cellular and molecular neurobiology. vol 25. issue 2. 2005-09-01. PMID:16047547. |
considering these results we suggest that (i) no may modulate motor behavior, probably by interfering with dopaminergic, serotonergic, and cholinergic neurotransmission in the striatum; (ii) subchronic no synthesis inhibition induces plastic changes in no-producing neurons in brain areas related to motor control and causes cross-tolerance to the cataleptic effect of haloperidol, raising the possibility that such treatments could decrease motor side effects associated with antipsychotic medications. |
2005-09-01 |
2023-08-12 |
mouse |
| P Mohapel, H Frielingsdorf, J Häggblad, O Zachrisson, P Brundi. Platelet-derived growth factor (PDGF-BB) and brain-derived neurotrophic factor (BDNF) induce striatal neurogenesis in adult rats with 6-hydroxydopamine lesions. Neuroscience. vol 132. issue 3. 2005-08-30. PMID:15837137. |
both in the striatum and in the substantia nigra there were no indications of any newly born cells differentiating into dopaminergic neurons following growth factor treatment, such that brdu-labeled cells never co-expressed tyrosine hydroxylase, the rate-limiting enzyme in dopamine synthesis. |
2005-08-30 |
2023-08-12 |
rat |